COST-EFFECTIVENESS OF PEMBROLIZUMAB AS AN ADJUVANT TREATMENT FOR RENAL CELL CARCINOMA POST-NEPHRECTOMY IN FRANCE

被引：0
|
作者：
Apert, M. [1 ]
Bensimon, L. [1 ]
Marie, L. [2 ]
Chau, M. [3 ]
Baluni, G. [4 ]
Chhabra, N. [4 ]
Kundu, A. [4 ]
Bhattacharya, R. [5 ]
Lai, Y. [5 ]
Gross-Goupil, M. [6 ]
Ouzaid, I [7 ]
机构：
[1] IMSD France, Puteaux La Defense 92, France
[2] Steve Consultants, Paris, France
[3] Steve Consultants, Paris 75, France
[4] Complete HEOR Solut, N Wales, PA USA
[5] Merck & Co Inc, Rahway, NJ USA
[6] Hop St Andre, CHU Bordeaux, Bordeaux, France
[7] Hop Bichat Claude Bernard, Paris, France
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE671
引用
收藏
页码：S183 / S183
页数：1
相关论文
共 50 条
  • [31] A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma
    Chan, Alan
    Dang, Carolyn
    Wisniewski, Jessica
    Weng, Xiuhua
    Hynson, Edward
    Zhong, Lixian
    Wilson, Leslie
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (02): : 66 - 73
  • [32] Cost-Effectiveness in the Surgical Care of Renal Cell Carcinoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (03) : 177 - 179
  • [33] The Prognostic Value of Erythrocyte Polyamine in the Post-Nephrectomy Stratification of Renal Cell Carcinoma Specific Mortality
    Bigot, Pierre
    Lughezzani, Giovanni
    Karakiewicz, Pierre
    Perrotte, Paul
    Rioux-Leclercq, Nathalie
    Catros-Quemener, Veronique
    Bouet, Francoise
    Moulinoux, Jean-Philippe
    Cipolla, Bernard
    Patard, Jean Jacques
    JOURNAL OF UROLOGY, 2010, 183 (02): : 486 - 491
  • [34] Cost-effectiveness of sunitinib in metastatic renal cell carcinoma
    Purmonen, Timo T.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (04) : 383 - 393
  • [35] Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma
    Hoyle, Martin
    Green, Colin
    Thompson-Coon, Jo
    Liu, Zulian
    Welch, Karen
    Moxham, Tiffany
    Stein, Ken
    VALUE IN HEALTH, 2010, 13 (01) : 61 - 68
  • [36] COST-EFFECTIVENESS OF PAZOPANIB COMPARED TO SUNITINIB IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA
    Fouad, A.
    Atia, A.
    Omar, Y.
    Shawky, M.
    Sakr, M.
    VALUE IN HEALTH, 2016, 19 (07) : A733 - A734
  • [37] Cost-Effectiveness of Frontline Treatment for Advanced Renal Cell Carcinoma in the Era of Immunotherapies
    Li, SiNi
    Li, JianHe
    Peng, LiuBao
    Li, YaMin
    Wan, XiaoMin
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] Metastatic Renal Cell Carcinoma to the Pancreas 13 Years Post-Nephrectomy: A Case Report and Review of the Literature
    Thadani, Anisha
    Pais, Shireen
    Savino, John
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S192 - S193
  • [39] The Prognostic Value of Erythrocyte Polyamine in the Post-Nephrectomy Stratification of Renal Cell Carcinoma Specific Mortality COMMENT
    Maranchie, Jodi K.
    JOURNAL OF UROLOGY, 2010, 183 (02): : 492 - 492
  • [40] Late-Onset Metastasis of Renal Cell Carcinoma: A Rare Case of Sinonasal Malignancy Post-Nephrectomy
    Vashisth, Swati
    Gupta, Ayushi
    Chaudhary, Ankita
    Aggarwal, Poonam
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2024, : 6055 - 6058
12345